Key result
Early coronary angiography in NSTE-ACS did not reduce the risk of death or MI, but reduced recurrent ischaemia.
Why the study?
The optimal timing of coronary angiography and subsequent intervention in patients with NSTE-ACS has not been settled.
Does early coronary angiography reduce death, MI, or recurrent ischemia compared to delayed angiography in patients with NSTE-ACS?
Meta-Analysis (n=4,013)
Yes
Does early coronary angiography reduce death, MI, or recurrent ischemia compared to delayed angiography in patients with NSTE-ACS?
Answers are grounded in this paper and cite their sources.
In patients with NSTE-ACS, an early invasive strategy does not significantly reduce death or MI compared to a delayed strategy, but it does reduce recurrent ischemia and hospital length of stay.
AIMS: An invasive approach is superior to medical management for the treatment of patients with acute coronary syndromes without ST-segment elevation (NSTE-ACS), but the optimal timing of coronary angiography and subsequent intervention, if indicated, has not been settled. METHODS AND RESULTS: We conducted a meta-analysis of randomized trials addressing the optimal timing (early vs. delayed) of coronary angiography in NSTE-ACS. Four trials with 4013 patients were eligible (ABOARD, ELISA, ISAR-COOL, TIMACS), and data for longer follow-up periods than those published became available for this meta-analysis by the ELISA and ISAR-COOL investigators. The median time from admission or randomization to coronary angiography ranged from 1.16 to 14 h in the early and 20.8-86 h in the delayed strategy group. No statistically significant difference of risk of death [random effects risk ratio (RR) 0.85, 95% confidence interval (CI) 0.64-1.11] or myocardial infarction (MI) (RR 0.94, 95% CI 0.61-1.45) was detected between the two strategies. Early intervention significantly reduced the risk for recurrent ischaemia (RR 0.59, 95% CI 0.38-0.92, P = 0.02) and the duration of hospital stay (by 28%, 95% CI 22-35%, P < 0.001). Furthermore, decreased major bleeding events (RR 0.78, 95% CI 0.57-1.07, P = 0.13), and less major events (death, MI, or stroke) (RR 0.91, 95% CI 0.82-1.01, P = 0.09) were observed with the early strategy but these differences were not nominally significant. CONCLUSION: Early coronary angiography and potential intervention reduces the risk of recurrent ischaemia, and shortens hospital stay in patients with NSTE-ACS.
No takes yet. Share an insight, caveat, or question.
Demosthenes G. Katritsis (2010) conducted a meta-analysis in acute coronary syndromes without ST-segment elevation (NSTE-ACS) (n=4,013). Early coronary angiography vs. Delayed coronary angiography was evaluated on death (RR 0.85, 95% CI 0.64-1.11). Early coronary angiography in NSTE-ACS did not reduce the risk of death or MI, but reduced recurrent ischaemia.
Synapse has enriched 10 related papers. Consider them for comparative context: